American College of Cardiology
American College of Cardiology
April 06, 2018
5 min watch
Save

VIDEO: Genotyping may influence antiplatelet therapy prescriptions

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In this Cardiology Today video exclusive, Sony Tuteja, PharmD, MS, research assistant professor of translational medicine and human genetics at Penn Medicine, and Jay S. Giri, MD, MPH, director of peripheral intervention and assistant professor of medicine at the Hospital of the University of Pennsylvania and a Cardiology Today Next Gen Innovator, discuss the results of the ADAPT trial.

The results of the study, presented at the American College of Cardiology Scientific Session, showed that performing a genetic test for nonresponse to clopidogrel frequently but not exclusively influences physician choice of antiplatelet prescription after PCI.

Watch the video for more.